Grade My Investments
Home › Free Stock Grades › PSNL

Personalis, Inc. (PSNL) Stock Grade

PSNL · Healthcare

C
Grade updated: September 29, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$1.7B
P/E Ratio
—
Revenue Growth (YoY)
-17.7%
Net Margin
-116.7%
Return on Equity
—
Dividend Yield
None

About Personalis, Inc.'s fundamentals

Personalis is a healthcare diagnostics company with a market capitalization of $1.7 billion that is currently unprofitable, reporting a net loss in its latest annual statement with a net margin of -116.7%. The company experienced declining revenue, with a year-over-year contraction of 17.7%, indicating shrinking sales. As a pre-profitable diagnostics firm, Personalis does not pay dividends and operates with negative returns on equity, typical of companies in early commercialization phases investing heavily in research and development.

Track PSNL free — no credit card required. Live grade + monthly AI report →